top of page

Antheia Raises $73M in Series B Funding

Antheia, a Menlo Park CA-based synthetic biology company, raised $73M in Series B funding. The round was led by Viking Global Investors with participation from Sherpalo Ventures and Hillspire. The company intends to use the funds to expand its pipeline and scale production in global markets.

Read the article at

bottom of page